XHLD vs SKIN

For growth investors, The Beauty Health Company (SKIN) is the stronger pick with -10.

0% revenue growth year-over-year, versus -11. 4% for TEN Holdings, Inc. Common Stock (XHLD). Analysts rate The Beauty Health Company (SKIN) a "Hold" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, TEN Holdings, Inc.

Common Stock (XHLD) delivered a total return of -79. 3%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: XHLD returned -79. 3% versus SKIN's -91. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Beauty Health Company (SKIN) is the lower-risk stock at 2.

00β versus TEN Holdings, Inc. Common Stock's 2. 09β — meaning XHLD is approximately 5% more volatile than SKIN relative to the S&P 500. On balance sheet safety, TEN Holdings, Inc. Common Stock (XHLD) carries a lower debt/equity ratio of 119% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Beauty Health Company (SKIN) is pulling ahead at -10.

0% versus -11. 4% for TEN Holdings, Inc. Common Stock (XHLD). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -376. 7% for TEN Holdings, Inc. Common Stock. Over a 3-year CAGR, SKIN leads at -6. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Beauty Health Company (SKIN) is the more profitable company, earning -3.

2% net margin versus -628. 5% for TEN Holdings, Inc. Common Stock — meaning it keeps -3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SKIN leads at -6. 9% versus -432. 5% for XHLD. At the gross margin level — before operating expenses — XHLD leads at 78. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, TEN Holdings, Inc.

Common Stock (XHLD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XHLD: -79. 3%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XHLD (Communication Services) and SKIN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.